BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9787016)

  • 1. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex.
    Gulledge AT; Jaffe DB
    J Neurosci; 1998 Nov; 18(21):9139-51. PubMed ID: 9787016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex.
    Henze DA; González-Burgos GR; Urban NN; Lewis DA; Barrionuevo G
    J Neurophysiol; 2000 Dec; 84(6):2799-809. PubMed ID: 11110810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.
    Tseng KY; O'Donnell P
    J Neurosci; 2004 Jun; 24(22):5131-9. PubMed ID: 15175382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex.
    Gorelova N; Seamans JK; Yang CR
    J Neurophysiol; 2002 Dec; 88(6):3150-66. PubMed ID: 12466437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex.
    Gonzalez-Islas C; Hablitz JJ
    J Neurophysiol; 2001 Dec; 86(6):2911-8. PubMed ID: 11731547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro.
    Gorelova NA; Yang CR
    J Neurophysiol; 2000 Jul; 84(1):75-87. PubMed ID: 10899185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.
    Tseng KY; Lewis BL; Lipska BK; O'Donnell P
    Biol Psychiatry; 2007 Oct; 62(7):730-8. PubMed ID: 17207473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons.
    Alberto CO; Trask RB; Quinlan ME; Hirasawa M
    J Neurosci; 2006 Sep; 26(39):10043-50. PubMed ID: 17005867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Layer-specific effects of dopaminergic D1 receptor activation on excitatory synaptic trains in layer V mouse prefrontal cortical pyramidal cells.
    Leyrer-Jackson JM; Thomas MP
    Physiol Rep; 2018 Aug; 6(15):e13806. PubMed ID: 30073790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of dopamine d1/5 receptor modulation of post-spike/burst afterhyperpolarization to enhance neuronal excitability of layer v pyramidal neurons in prepubertal rat prefrontal cortex.
    Yi F; Zhang XH; Yang CR; Li BM
    PLoS One; 2013; 8(8):e71880. PubMed ID: 23977170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors.
    Tamae A; Nakatsuka T; Koga K; Kato G; Furue H; Katafuchi T; Yoshimura M
    J Physiol; 2005 Oct; 568(Pt 1):243-53. PubMed ID: 15975975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 and D4 receptor subtypes differentially modulate recurrent excitatory synapses in prefrontal cortical pyramidal neurons.
    Onn SP; Wang XB; Lin M; Grace AA
    Neuropsychopharmacology; 2006 Feb; 31(2):318-38. PubMed ID: 16052247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine enhances spatiotemporal spread of activity in rat prefrontal cortex.
    Bandyopadhyay S; Gonzalez-Islas C; Hablitz JJ
    J Neurophysiol; 2005 Feb; 93(2):864-72. PubMed ID: 15469958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons.
    Seamans JK; Gorelova N; Durstewitz D; Yang CR
    J Neurosci; 2001 May; 21(10):3628-38. PubMed ID: 11331392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study.
    Law-Tho D; Hirsch JC; Crepel F
    Neurosci Res; 1994 Dec; 21(2):151-60. PubMed ID: 7724066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of inhibitory and excitatory transmission in the basolateral amygdala-prefrontal cortical pathway.
    Floresco SB; Tse MT
    J Neurosci; 2007 Feb; 27(8):2045-57. PubMed ID: 17314300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex.
    Gulledge AT; Jaffe DB
    J Neurophysiol; 2001 Aug; 86(2):586-95. PubMed ID: 11495934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence.
    Ninan I; Wang RY
    Eur J Neurosci; 2003 Mar; 17(6):1306-12. PubMed ID: 12670320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
    Gioanni Y; Thierry AM; Glowinski J; Tassin JP
    Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.